Gilead Sciences (GILD) Return on Assets [ROA] (2009 - 2026)
Gilead Sciences' Return on Assets [ROA] came in at -6.13% for Q2 2026, down 17.39 percentage points from 11.25% a year earlier and down 22.12 percentage points from the prior quarter.
Gilead Sciences (GILD) Return on Assets [ROA] (2009 - 2026) Analysis & Trends
For FY2025, Gilead Sciences' Return on Assets [ROA] was 14.42%, up 13.63 percentage points from FY2024.
- Return on Assets [ROA] carries a five-year change of +14.28 percentage points (FY2020 to FY2025).
- Going back by year, Return on Assets [ROA] was 0.79% in FY2024 (-8.17 pp), 8.96% in FY2023 (+2.00 pp), 6.96% in FY2022 (-2.13 pp) and 9.10% in FY2021 (+8.96 pp).
- The Q2 2026 figure represents the lowest quarterly Return on Assets [ROA] in data going back to Q3 2009.
- Year-over-year, Return on Assets [ROA] increased in five of the last eight quarters, with an average year-over-year change of +2.19 percentage points.
- The fastest year-over-year change in Return on Assets [ROA] over five years came in Q3 2025 (a gain of 13.99 percentage points), and the weakest in Q2 2026 (a drop of 17.39 percentage points).
- Business Quant data shows GILD's Return on Assets [ROA] at 15.99% (Q1 2026), 14.48% (Q4 2025) and 14.20% (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 10.47% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 4.65% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.45% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 28.37% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 9.10% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 9.29% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -6.13% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 2.14% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 16.34% |
| 10 | Bristol Myers Squibb | 127.55 Bn | 78.82 Bn | 9.25 Bn | 10.65% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -6.13% |
| Mar 31, 2026 | 15.99% |
| Dec 31, 2025 | 14.48% |
| Sep 30, 2025 | 14.20% |
| Jun 30, 2025 | 11.25% |
| Mar 31, 2025 | 10.34% |
| Dec 31, 2024 | 0.85% |
| Sep 30, 2024 | 0.21% |
| Jun 30, 2024 | 1.88% |
| Mar 31, 2024 | 0.77% |
| Dec 31, 2023 | 9.02% |
| Sep 30, 2023 | 9.35% |
| Jun 30, 2023 | 8.76% |
| Mar 31, 2023 | 8.86% |
| Dec 31, 2022 | 7.26% |
| Sep 30, 2022 | 5.28% |
| Jun 30, 2022 | 6.52% |
| Mar 31, 2022 | 6.85% |
| Dec 31, 2021 | 9.18% |
| Sep 30, 2021 | 10.91% |
Gilead Sciences Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=GILD&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "GILD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=GILD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();